For every newly diagnosed BC, expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and proliferation marker protein Ki-67 is routinely determined, and according to these characteristics molecular or intrinsic subtypes of BC are defined. The gene discussed is ERBB2; the disease is breast cancer.